Skip to content

Evaluation of the Implementation of Expanded Carrier Screening Before Pregnancy in Hong Kong

Evaluation of the Implementation of Expanded Carrier Screening Before Pregnancy in Hong Kong

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02742116
Enrollment
100
Registered
2016-04-18
Start date
2016-07-31
Completion date
2016-10-31
Last updated
2016-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Testing

Keywords

Expanded carrier screening

Brief summary

The objectives are to: 1. Assess patient's views and preferences in receiving expanded carrier screening 2. Perform qualitative study on post testing counselling on screen positive individuals and at risk couples

Detailed description

This study is to recruit 50 couples for Expanded carrier screening at Prepregnancy Checkup Clinic at the Family Planning Association. Saliva swabs are collected from couples for Hereditary Disease DNA screening test by DrGene. Blood samples are taken by venipuncture of women for Fragile X carrier screening by Prenatal Diagnostic Laboratory, Tsan Yuk Hospital. A pre-test self-administered Questionnaire 1 will be administered to couples to assess their knowledge, views and preferences in receiving expanded carrier screening. This include collection of basic demographic information, answers to questions on basic principles of expanded carrier testing, reasons of having or declining the test, choice of having concurrent or sequential screening, factors affecting their choices, anxiety level of the patient is assessed by state-trait anxiety inventory. Their willingness to pay for the test is also assessed. The test results will be available to couples in 6 week's time. A post-test self-administered questionnaire 2 will be administered to couples on receiving the test results at the clinic. These include assessment of anxiety level, any decision regret, outcome of test and resulting action. The couples with a screen positive result will be referred to Queen Mary Hospital for a joint counselling by clinical geneticist and gynaecologist. This counselling/consultation shall be audiotaped or videotaped. The interviews will be transcribed verbatim. The data will be explored for themes and issues identified. Statistics Questionnaire survey data shall be entered into SPSS. Descriptive statistics will be used to compare responses and choices of participants.

Interventions

GENETICDNA screening before Pregnancy

Saliva/swab shall be collected from couple for Hereditary Disease DNA screening test. Blood sample shall be taken by venipuncture of women for Fragile X carrier screening A pre-test questionnaire will be conducted to assess subject's knowledge, views and preferences in receiving expanded carrier screening, choice of having concurrent or sequential screening, factors affecting their choices, anxiety level, and their willingness to pay for the test. A post-test self-administered questionnaire shall be filled in by the patient on receiving the test results. Couples who receive a screen positive result shall be subsequently referred to Queen Mary Hospital for joint counselling by clinical geneticist and gynaecologist. This consultation shall be audiotaped or videotaped.

Sponsors

The Family Planning Association of Hong Kong
CollaboratorOTHER
The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ethnic Chinese couples who attend prepregnancy clinic * Age 18 or above

Exclusion criteria

* Couples who cannot read or understand Chinese or English

Design outcomes

Primary

MeasureTime frameDescription
Patient acceptance and literacy of expanded carrier screening6 weeksFactors affecting the choice of expanded carrier screening in the prepregnancy and subfertility patients Identify counselling issues when expanded carrier screening is offered in the local setting

Secondary

MeasureTime frameDescription
Patient acceptance and literacy of expanded carrier screening6 monthscost, false positives, workload generated from offering expanded carrier screening

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026